Format

Send to

Choose Destination
Procedia Vaccinol. 2014 Jan 1;8:38-42.

Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates.

Author information

1
Tulane University School of Medicine, New Orleans LA 70112, USA.
2
Tulane National Primate Research Center, Covington LA 70433, USA.
3
Tulane University School of Medicine, New Orleans LA 70112, USA ; Tulane National Primate Research Center, Covington LA 70433, USA.

Abstract

Burkholderia pseudomallei (Bps)is the causative agent of melioidosis and is endemic in regions of northern Australia and Southeast Asia. Bps is inherently resistant to multiple antibiotics and is considered a potential biological warfare agent by the U.S. DHHS. Therefore, effective vaccines are necessary to prevent natural infection and to safeguard against biological attack with this organism. In our previous work we have shown that immunization with naturally derived outer membrane vesicles (OMVs) from Bps provides significant protection against lethal aerosol and systemic infection in BALB/c mice. In this work, we evaluated the safety and immunogenicity of escalating doses of OMV vaccine in rhesus macaques. We show that immunization of rhesus macaques with Bps OMVs generates humoral immuneresponses to protective protein and polysaccharide antigens without any associated toxicity or reactogenicity. These results lay the groundwork for evaluation of protective efficacy of the OMV vaccine in the nonhuman primate model of melioidosis.

KEYWORDS:

Burkholderia pseudomallei; Outer membrane vesicle; melioidosis; primate; vaccine

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center